This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bhadrasain Vikram, MD

Arch Otolaryngol. 1984;110(9):564-565.

Abstract
• We treated 98 previously untreated patients with stages III and IV resectable epidermoid carcinoma of the oral cavity, oropharynx, and larynx with surgery and postoperative radiation therapy. The reasons for postoperative radiation therapy were unsatisfactory surgical margins in 36 patients, cervical metastases at multiple levels pathologically in 49, and both in 13. Historically, patients with similar findings, treated by surgery alone at our institution, had a relapse rate above the clavicles of more than 70% within two years. In the present series only 15% have had relapses above the clavicles, and distant metastases developed in another 20%. In addition, approximately 6% of patients per year have had second malignant neoplasms develop, predominantly in the esophagus or the lung. These changes in the patterns of failure have implications for future studies aimed at improving the cure rate and the survival of these patients.

(Arch Otolaryngol 1984;110:564-565)

Author Affiliations
From the Department of Radiation Therapy, Memorial Sloan-Kettering Cancer Center, New York.

Footnotes
Accepted for publication March 5, 1984.

Reprint requests to Department of Radiation Therapy, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (Dr Vikram).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer
Wu et al.
Clin. Cancer Res. 2006;12:7194-7201.
ABSTRACT | FULL TEXT  

Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients.
Khuri et al.
JNCI J Natl Cancer Inst 2006;98:441-450.
ABSTRACT | FULL TEXT  

A Randomized Trial of an Intervention to Increase Fruit and Vegetable Intake in Curatively Treated Patients with Early-Stage Head and Neck Cancer
Cartmel et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2848-2854.
ABSTRACT | FULL TEXT  

Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer: A Retrospective Study
Tabor et al.
Clin. Cancer Res. 2004;10:3607-3613.
ABSTRACT | FULL TEXT  

The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial
Khuri et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:823-829.
ABSTRACT | FULL TEXT  

Dr Martin: How Are We Doing in 2000?: Hayes Martin Lecture
Byers
Arch Otolaryngol Head Neck Surg 2001;127:759-765.
FULL TEXT  

Comparison of Low-Dose Isotretinoin with Beta Carotene to Prevent Oral Carcinogenesis
Lippman et al.
NEJM 1993;328:15-20.
ABSTRACT | FULL TEXT  

Unknown Primary Squamous Cell Carcinoma Metastatic to the Neck
Wang et al.
Arch Otolaryngol Head Neck Surg 1990;116:1388-1393.
ABSTRACT  

Irradiation After Neck Dissection
VIKRAM et al.
Arch Otolaryngol Head Neck Surg 1985;111:827-828.
ABSTRACT  

Are We Making Any Progress?
GOEPFERT
Arch Otolaryngol Head Neck Surg 1984;110:562-563.
ABSTRACT